DDX50P1

Across TCGA pan-cancer cohorts, DDX50P1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of DDX50P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where DDX50P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DDX50P1 is over-expressed in tumor.

COAD, HNSC, and BLCA are the cancer types where DDX50P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DDX50P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+0.441	<.001	12	view →
HNSC	Female	All	+0.162	<.001	11	view →
BLCA	All	All	+0.469	<.001	10	view →
LUAD	Male	All	+0.424	<.001	6	view →
LUSC	All	All	+0.340	<.001	6	view →
READ	Male	All	+0.286	.001	6	view →
KIRC	All	All	+0.094	<.001	6	view →
STAD	All	II,III,IV	+0.323	<.001	5	view →
LIHC	All	All	+0.056	.001	5	view →
CHOL	All	All	+0.564	<.001	4	view →
BRCA	All	II,III,IV	+0.141	.003	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

DDX50P1–COAD

Open the COAD breakdown →